Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02305056 : Study of Tumor Metabolism by Isotopic Tagging in Patients With High-grade Glioma (CARBONOMIC)
PhasePhase 1
AgesMin: 18 Years Max: 90 Years
Eligibility
Inclusion Criteria:

- more or equal than 18 years old

- patient affiliated to social security or similarly regime

- informed consent form signed

- High-grade Glioma tumor suspicion

- Resective surgery indication

- Hematological assessment :

- neutrophils > 1500/mm3

- Platelet > 150 000

- blood Creatinin normal

- alkaline Phosphatases and transaminases no more than two times normal

- Bilirubin < 1.5 times normal

Exclusion Criteria:

- Pregnant women and lactating mothers

- Ward of court or under guardianship

- Adult unable to express their consent

- Person deprived of freedom by judicial or administrative decision

- Person hospitalized without their consent

- Person under legal protection

- Precedent complete macroscopic tumor resective surgery

- No valid inclusion criteria

- Intratumoral hemorrhage MRI detected

- Treatment anticoagulant or antisludge treatments

- Active Infections and non controled or medical affection or psychiatric intercurrent
non treated

- Evolutive cerebral oedema without corticoid response

- Non controled Epilepsy without antiepileptics response

- Karnofsky score < 40%

- Weight > 100 kg

- No possibility of resective surgery
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02305056      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740